교수소개

윤아일린 부교수

■ 자기소개

현재 한양대학교 의과대학 내과학 교실에 재직 중으로 고려대학교를 졸업하고 현재 한양대학교 병원 소화기내과에 근무하고 있다. 주요 관심사는 간질환이다.

 

 

■ 학력

2000.3- 2006.2 고려대학교 의과대학 의학사

2008.9- 2010.8 고려대학교 의과대학원 의학석사

2010.9- 2013.8 고려대학교 의과대학원 의학박사

 

 

■ 경력

2011.3-2011.9 고려대학교 안산병원 소화기내과 임상강사

2011.10-2014.2 고려대학교 구로병원 소화기내과 임상강사

2014.3-2020.3 인제대학교 상계백병원 소화기내과 조교수

2020.4-2021.2 인제대학교 상계백병원 소화기내과 부교수

 

 

■ 연구분야 

간경변, 간암, 알코올성 간질환

 

 

■ 주요논문

주저자

1. No Difference in Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection Treated With Entecavir Vs Tenofovir.

Oh H, Yoon EL, Jun DW, Ahn SB, Lee HY, Jeong JY, Kim HS, Jeong SW, Kim SE, Shim JJ, Sohn JH, Cho YK; Long-Term Safety of Entecavir and Tenofovir in Patients With Treatment-Naive Chronic Hepatitis B Virus (CHB) Infection (SAINT) Study.

Clin Gastroenterol Hepatol. 2020 Mar 2:S1542-3565(20)30265-2. doi: 10.1016/j.cgh.2020.02.046. Online ahead of print.

2. Editorial: comorbidities in patients with chronic hepatitis B-authors' reply.

Yoon EL, Oh H, Jun DW, Nguyen MH.

Aliment Pharmacol Ther. 2020 Sep;52(5):893-894. doi: 10.1111/apt.15979.

3. Validation of the Korean Stroop Test in Diagnosis of Minimal Hepatic Encephalopathy.

Yoon EL, Jun DW, Jeong JY, Kim TY, Song DS, Ahn SB, Kim HY, Jung YK, Song MJ, Kim SE, Kim HS, Jeong SW, Kim SG, Lee TH, Cho YK, Kim JK, Ryu H.

Sci Rep. 2019 May 29;9(1):8027. doi: 10.1038/s41598-019-44503-w.

4. The Impact of Previous Acute Decompensation on the Long-Term Prognosis of Alcoholic Hepatitis in Cirrhotic Patients.

Yoon EL, Kim TY, Song DS, Kim HY, Kim CW, Jung YK, Sinn DH, Jang JY, Kim MY, Jeong SW, Kim SG, Suk KT, Kim DJ, Liver Failure KACLiF Study Group OBOTKA.

J Clin Med. 2019 Oct 3;8(10):1600. doi: 10.3390/jcm8101600.

5. Updated Treatment of Chronic Hepatitis B.

Yoon EL, Yim HJ.

Korean J Med. 2019 Jun;94(3):252-262. Korean. Practice Guideline.

6. Prophylactic Antiviral Treatment in Immunosuppressed Chronic Hepatitis B Patients.

Yoon EL.

Korean J Gastroenterol. 2019 Nov 25;74(5):258-266. doi: 10.4166/kjg.2019.74.5.258.

7. Long-term Prognosis of Acute-on-Chronic Liver Failure Survivors.

Yoon EL, Kim TY, Lee CH, Kim TH, Cho HC, Lee SS, Kim SE, Kim HY, Kim CW, Song DS, Yang JM, Sinn DH, Jung YK, Yim HJ, Kim HS, Sohn JH, Kim JH, Choe WH, Lee BS, Kim MY, Jeong SW, Choi E, Kim DJ; Korean Acute-on-Chronic Liver Failure (KACLiF) Study Group.

J Clin Gastroenterol. 2019 Feb;53(2):134-141. doi: 10.1097/MCG.0000000000000987.

8. Clinical Significance of Urinary Neutrophil Gelatinase-associated Lipocalin Levels in Defining the Various Etiologies of Acute Kidney Injury in Liver Cirrhosis Patients.

Lee JH, Yoon EL, Park SE, Park JY, Choi JM, Jeon TJ, Shin WC, Choi WC.

Korean J Gastroenterol. 2019 Oct 25;74(4):212-218. doi: 10.4166/kjg.2019.74.4.212.

9. Current status and strategies for the control of viral hepatitis A in Korea.

Yoon EL, Sinn DH, Lee HW, Kim JH.

Clin Mol Hepatol. 2017 Sep;23(3):196-204. doi: 10.3350/cmh.2017.0034. Epub 2017 Sep 19. Review.

10. A Case of Combined Hepatocellular-cholangiocarcinoma Mimicking Pyogenic Liver Abscess.

Baek SS, Yoon EL, Kim HJ, Bae KE, Park K, Choi WC.

J Liver Cancer. 2017 Sep;17(2):174-181. Korean. Case Report.

11. An Explorative Analysis for the Role of Serum miR-10b-3p Levels in Predicting Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

Yoon EL, Yeon JE, Ko E, Lee HJ, Je JH, Yoo YJ, Kang SH, Suh SJ, Kim JH, Seo YS, Yim HJ, Byun KS.

J Korean Med Sci. 2017 Feb;32(2):212-220. doi: 10.3346/jkms.2017.32.2.212.

12. Systemic cytotoxic chemotherapy of patients with advanced hepatocellular carcinoma in the era of sorafenib nonavailability.

Yoon EL, Yeon JE, Lee HJ, Suh SJ, Lee SJ, Kang SH, Kang K, Yoo YJ, Kim JH, Yim HJ, Byun KS.

J Clin Gastroenterol. 2014 Mar;48(3):e22-9. doi: 10.1097/MCG.0b013e3182a54ec8.

 

공저자

1. Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure.

Wong F, Piano S, Singh V, Bartoletti M, Maiwall R, Alessandria C, Fernandez J, Soares EC, Kim DJ, Kim SE, Marino M, Vorobioff J, de Cassia Ribeiro Barea R, Merli M, Elkrief L, Vargas V, Krag A, Singh SP, Lesmana LA, Toledo C, Marciano S, Verhelst X, Intagliata N, Rabinowich L, Colombato L, Kim SG, Gerbes A, Durand F, Roblero JP, Bruns T, Yoon EL, Girala M, Pyrsopoulos NT, Kim TH, Yim SY, Juanola A, Gadano A, Angeli P; International Club of Ascites Global Study Group.

J Hepatol. 2020 Aug 8:S0168-8278(20)30533-X. doi: 10.1016/j.jhep.2020.07.046. Online ahead of print.

2. Multiplexed Proteomic Approach for Identification of Serum Biomarkers in Hepatocellular Carcinoma Patients with Normal AFP.

Lee YS, Ko E, Yoon EL, Jung YK, Kim JH, Seo YS, Yim HJ, Kim KH, Kwon SY, Yeon JE, Um SH, Byun KS.

J Clin Med. 2020 Jan 23;9(2):323. doi: 10.3390/jcm9020323.

3. Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis.

Ahn YE, Suh SJ, Yim HJ, Seo YS, Yoon EL, Kim TH, Lee YS, Yim SY, Kim HR, Kang SH, Jung YK, Kim JH, Yeon JE, Um SH, Byun KS.

Gut Liver. 2020 Apr 22. doi: 10.5009/gnl19367. Online ahead of print.

4. Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop.

Yim HJ, Kim JH, Park JY, Yoon EL, Park H, Kwon JH, Sinn DH, Lee SH, Lee JH, Lee HW.

Clin Mol Hepatol. 2020 Aug 28. doi: 10.3350/cmh.2020.0049. Online ahead of print.

5. Tenofovir-based combination therapy or monotherapy for multidrug-resistant chronic hepatitis B: Long-term data from a multicenter cohort study.

Yim HJ, Suh SJ, Jung YK, Hwang SG, Seo YS, Um SH, Lee SH, Kim YS, Jang JY, Kim IH, Kim HS, Kim JH, Lee YS, Yoon EL, Song MJ, Park JY.

J Viral Hepat. 2020 Jul 24. doi: 10.1111/jvh.13363. Online ahead of print.

6. Differential Impact of Serum 25-Hydroxyvitamin D3 Levels on the Prognosis of Patients with Liver Cirrhosis According to MELD and Child-Pugh Scores.

Kim TH, Yun SG, Choi J, Goh HG, Lee HA, Yim SY, Choi SJ, Lee YS, Yoon EL, Jung YK, Seo YS, Kim JH, Yim HJ, Yeon JE, Byun KS, Um SH.

J Korean Med Sci. 2020 May 18;35(19):e129. doi: 10.3346/jkms.2020.35.e129.

7. Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding.

Shin J, Yu JH, Jin YJ, Yim HJ, Jung YK, Yang JM, Song DS, Kim YS, Kim SG, Kim DJ, Suk KT, Yoon EL, Lee SS, Kim CW, Kim HY, Jang JY, Jeong SW; Korean Acute-onChronic Liver Failure (KACLiF) Study Group.

Clin Mol Hepatol. 2020 Sep 17. doi: 10.3350/cmh.2020.0034. Online ahead of print.

8. HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication.

Ogawa E, Toyoda H, Iio E, Jun DW, Huang CF, Enomoto M, Hsu YC, Haga H, Iwane S, Wong G, Lee DH, Tada T, Liu CH, Chuang WL, Hayashi J, Cheung R, Yasuda S, Tseng CH, Takahashi H, Tran S, Yeo YH, Henry L, Barnett SD, Nomura H, Nakamuta M, Dai CY, Huang JF, Yang HI, Lee MH, Jung Jun M, Kao JH, Eguchi Y, Ueno Y, Tamori A, Furusyo N, Yu ML, Tanaka Y, Nguyen MH; REAL-C Investigators, Ahn SB, Azuma K, Dohmen K, Yoon Jeong J, Jung JH, Kajiwara E, Kato M, Kawano A, Koyanagi T, Ooho A, Park SH, Satoh T, Shimoda S, Song DS, Takahashi K, Yeh ML, Yoon EL.

Clin Infect Dis. 2019 Nov 28:ciz1160. doi: 10.1093/cid/ciz1160. Online ahead of print.

9. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.

Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Rastogi A, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Alam S, Song DS, Yang JM, Yoon EL; APASL ACLF Research Consortium (AARC) for APASL ACLF working Party.

Hepatol Int. 2019 Jun 6. doi: 10.1007/s12072-019-09946-3. [Epub ahead of print]

10. Validation of prognostic scores to predict short-term mortality in patients with acute-on-chronic liver failure.

Song DS, Kim TY, Kim DJ, Kim HY, Sinn DH, Yoon EL, Kim CW, Jung YK, Suk KT, Lee SS, Lee CH, Kim TH, Choe WH, Yim HJ, Kim SE, Baik SK, Jang JY, Kim HS, Kim SG, Yang JM, Sohn JH, Choi EH, Cho HC, Jeong SW, Kim MY; Korean Acute-on-Chronic Liver Failure (KACLiF) Study Group.

J Gastroenterol Hepatol. 2018 Apr;33(4):900-909. doi: 10.1111/jgh.13991. Epub 2018 Feb 26.

11. Validation of a Paper and Pencil Test Battery for the Diagnosis of Minimal Hepatic Encephalopathy in Korea.

Jeong JY, Jun DW, Bai D, Kim JY, Sohn JH, Ahn SB, Kim SG, Kim TY, Kim HS, Jeong SW, Cho YK, Song DS, Kim HY, Jung YK, Yoon EL.

J Korean Med Sci. 2017 Sep;32(9):1484-1490. doi: 10.3346/jkms.2017.32.9.1484.

12. Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis.

Kim HY, Kim CW, Kim TY, Song DS, Sinn DH, Yoon EL, Jung YK, Suk KT, Lee SS, Lee CH, Kim TH, Kim JH, Yim HJ, Kim SE, Baik SK, Lee BS, Jang JY, Kim YS, Kim SG, Yang JM, Sohn JH, Lee HJ, Park SH, Choi EH, Kim DJ; Korean Acute-on-Chronic Liver Failure Study Group.

World J Gastroenterol. 2016 Nov 7;22(41):9205-9213.

13. Antiviral response is not sustained after cessation of lamivudine treatment in chronic hepatitis B patients: A 10-year follow-up study.

Kang SH, Kang K, Jong Eun Y, Lee YS, Kim TS, Yoo YJ, Suh SJ, Yoon EL, Jung YK, Kim JH, Seo YS, Yim HJ, Byun KS.

J Med Virol. 2017 May;89(5):849-856. doi: 10.1002/jmv.24715. Epub 2016 Dec 23.

14. Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition.

Kim TY, Song DS, Kim HY, Sinn DH, Yoon EL, Kim CW, Jung YK, Suk KT, Lee SS, Lee CH, Kim TH, Kim JH, Choe WH, Yim HJ, Kim SE, Baik SK, Lee BS, Jang JY, Suh J 3rd, Kim HS, Nam SW, Kwon HC, Kim YS, Kim SG, Chae HB, Yang JM, Sohn JH, Lee HJ, Park SH, Han BH, Choi EH, Kim CH, Kim DJ; Korean Acute-on-Chronic Liver Failure Study Group.

PLoS One. 2016 Jan 20;11(1):e0146745. doi: 10.1371/journal.pone.0146745. eCollection 2016.

15. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.

Lee HJ, Yeon JE, Ko EJ, Yoon EL, Suh SJ, Kang K, Kim HR, Kang SH, Yoo YJ, Je J, Lee BJ, Kim JH, Seo YS, Yim HJ, Byun KS.

World J Gastroenterol. 2015 Dec 7;21(45):12787-99. doi: 10.3748/wjg.v21.i45.12787.

.

16. Long-term follow-up of chronic hepatitis C patients treated with interferon-alpha: risk of cirrhosis and hepatocellular carcinoma in a single center over 10 years.

Lee HJ, Yeon JE, Yoon EL, Suh SJ, Kang K, Kim HR, Kang SH, Yoo YJ, Je J, Kim JH, Seo YS, Yim HJ, Byun KS.

Intervirology. 2015;58(1):14-21. doi: 10.1159/000369206. Epub 2015 Jan 10.

17. Clinical utility of plasma glypican-3 and osteopontin as biomarkers of hepatocellular carcinoma.

Lee HJ, Yeon JE, Suh SJ, Lee SJ, Yoon EL, Kang K, Yoo YJ, Kim JH, Seo YS, Yim HJ, Byun KS.

Gut Liver. 2014 Mar;8(2):177-85. doi: 10.5009/gnl.2014.8.2.177. Epub 2013 Dec 24.

18. Is propofol safe when administered to cirrhotic patients during sedative endoscopy?

Suh SJ, Yim HJ, Yoon EL, Lee BJ, Hyun JJ, Jung SW, Koo JS, Kim JH, Kim KJ, Choung RS, Seo YS, Yeon JE, Um SH, Byun KS, Lee SW, Choi JH, Ryu HS.

Korean J Intern Med. 2014 Jan;29(1):57-65. doi: 10.3904/kjim.2014.29.1.57. Epub 2014 Jan 2.

19. Efficacy and safety of tenofovir-based rescue therapy for chronic hepatitis B patients with previous nucleo(s/t)ide treatment failure.

Lee CI, Kwon SY, Kim JH, Choe WH, Lee CH, Yoon EL, Yeon JE, Byun KS, Kim YS, Kim JH.

Gut Liver. 2014 Jan;8(1):64-9. doi: 10.5009/gnl.2014.8.1.64. Epub 2013 Nov 5.

20. Comparison of lamivudine plus adefovir therapy versus entecavir with or without adefovir therapy for adefovir-resistant chronic hepatitis B.

Kang SH, Yim HJ, Kim HR, Kang K, Suh SJ, Lee HJ, Yoon EL, Kim JH, Seo YS, Yeon JE, Byun KS.

J Clin Gastroenterol. 2014 Nov-Dec;48(10):889-95. doi: 10.1097/MCG.0000000000000066.

 

 

■ 학회활동

대한간학회 연구기획위원, 보험위원

대한간암학회 간행위원

 

 

■ 수상경력

2013년 6월 15일 The liver week 2013 Best presentation award (대한간학회) 수상

2016년 6월 18일 The liver week 2016 Best presentation award (대한간학회) 수상

2018년 6월 16일 The liver week 2018 Best presentation award (대한간학회) 수상

2020년 4월 3일 인제대학교 상계백병원 학술상 우수논문상 수상